"OP0223 ABATACEPT IN THE TREATMENT OF ACTIVE PSORIATIC ARTHRITIS: 1-YEAR RESULTS FROM A PHASE III STUDY. The European League against Rheumatism (EULAR) Annual European Congress of Rheumatology, Madrid, June 2017." by Philip Mease

Presentation

OP0223 ABATACEPT IN THE TREATMENT OF ACTIVE PSORIATIC ARTHRITIS: 1-YEAR RESULTS FROM A PHASE III STUDY. The European League against Rheumatism (EULAR) Annual European Congress of Rheumatology, Madrid, June 2017.

The European League against Rheumatism (EULAR) Annual European Congress of Rheumatology (2017)

Philip Mease, Providence St. Joseph Health
et.al.

Link

Disciplines

Rheumatology

Publication Date

June, 2017

Citation Information

Philip Mease and et.al.. "OP0223 ABATACEPT IN THE TREATMENT OF ACTIVE PSORIATIC ARTHRITIS: 1-YEAR RESULTS FROM A PHASE III STUDY. The European League against Rheumatism (EULAR) Annual European Congress of Rheumatology, Madrid, June 2017." The European League against Rheumatism (EULAR) Annual European Congress of Rheumatology (2017)
Available at: http://works.bepress.com/philip-mease/256/